Cargando…

Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade

Detalles Bibliográficos
Autores principales:	Miri, Seyed Mohammad, Ebrahimzadeh, Mir Saeed, Abdolalipour, Elahe, Yazdi, Mahsa, Ravandi, Hassan Hosseini, Ghaemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594438/ https://www.ncbi.nlm.nih.gov/pubmed/33132759 http://dx.doi.org/10.1186/s12935-020-01610-3

Ejemplares similares

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Correction to: Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
por: Mahooti, Mehran, et al.
Publicado: (2020)

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014)

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
por: Simpson, G R, et al.
Publicado: (2012)

Bovine Lactoferrin Prevents Influenza A Virus Infection by Interfering with the Fusogenic Function of Viral Hemagglutinin
por: Superti, Fabiana, et al.
Publicado: (2019)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
por: Takaoka, Hiroo, et al.
Publicado: (2011)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
por: Ghaemi, Amir, et al.
Publicado: (2022)

Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion
por: Hamilton, Brian S., et al.
Publicado: (2012)

Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma
por: Krabbe, Teresa, et al.
Publicado: (2021)

Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022)

Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
por: Fournier, Philippe, et al.
Publicado: (2013)

Therapeutic potential of oncolytic Newcastle disease virus: a critical review
por: Tayeb, Shay, et al.
Publicado: (2015)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

Structural basis of malaria transmission blockade by a monoclonal antibody to gamete fusogen HAP2
por: Feng, Juan, et al.
Publicado: (2021)

Influence of Membrane–Fusogen Distance on the Secondary Structure of Fusogenic Coiled Coil Peptides
por: Daudey, Geert A., et al.
Publicado: (2019)

Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240
por: GHRICI, MOHAMED, et al.
Publicado: (2013)

Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021)

Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan
por: MASE, Masaji
Publicado: (2021)

CELL BLOCKADE IN NEWCASTLE DISEASE OF CHICKENS AND CHICKEN EMBRYOS
por: Bang, F. B.
Publicado: (1949)

Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif “RRQRRL” are critical for fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts
por: Wang, Wenbin, et al.
Publicado: (2021)

Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
por: Yurchenko, K. S., et al.
Publicado: (2019)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Fusogenic structural changes in arenavirus glycoproteins are associated with viroporin activity
por: Zhang, You, et al.
Publicado: (2023)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy
por: Gu, Min, et al.
Publicado: (2011)

Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
por: Firouzamandi, Masoumeh, et al.
Publicado: (2016)

Virulence Potential of Fusogenic Orthoreoviruses
por: Wong, Ann H., et al.
Publicado: (2012)

Virus and eukaryote fusogen superfamilies
por: Vance, Tyler D.R., et al.
Publicado: (2020)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
por: Schirrmacher, Volker, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0a6q5ufavpnou93ifluv913pfs